UBS Group AG cut its holdings in shares of BlackRock Capital Allocation Term Trust (NYSE:BCAT – Free Report) by 15.6% during the 4th quarter, HoldingsChannel.com reports. The fund owned 960,501 shares of the company’s stock after selling 178,177 shares during the period. UBS Group AG’s holdings in BlackRock Capital Allocation Term Trust were worth $13,601,000 at the end of the most recent quarter.
Other hedge funds and other institutional investors have also recently added to or reduced their stakes in the company. Keener Financial Planning LLC bought a new position in BlackRock Capital Allocation Term Trust during the third quarter worth about $29,000. Geneos Wealth Management Inc. lifted its holdings in BlackRock Capital Allocation Term Trust by 341.7% during the second quarter. Geneos Wealth Management Inc. now owns 2,045 shares of the company’s stock worth $31,000 after acquiring an additional 1,582 shares in the last quarter. N.E.W. Advisory Services LLC lifted its holdings in BlackRock Capital Allocation Term Trust by 100.0% during the fourth quarter. N.E.W. Advisory Services LLC now owns 2,400 shares of the company’s stock worth $34,000 after acquiring an additional 1,200 shares in the last quarter. Parallel Advisors LLC bought a new position in BlackRock Capital Allocation Term Trust during the third quarter worth about $47,000. Finally, Brown Brothers Harriman & Co. lifted its holdings in BlackRock Capital Allocation Term Trust by 450.0% during the third quarter. Brown Brothers Harriman & Co. now owns 5,500 shares of the company’s stock worth $81,000 after acquiring an additional 4,500 shares in the last quarter. 36.12% of the stock is currently owned by institutional investors.
BlackRock Capital Allocation Term Trust Trading Down 0.0%
BCAT stock opened at $15.72 on Friday. The business’s 50-day moving average price is $14.84 and its two-hundred day moving average price is $14.66. BlackRock Capital Allocation Term Trust has a 1-year low of $13.73 and a 1-year high of $15.89.
BlackRock Capital Allocation Term Trust Dividend Announcement
About BlackRock Capital Allocation Term Trust
BlackRock Capital Allocation Term Trust (NYSE: BCAT) is a closed-end, diversified management investment company organized as a term trust. The fund’s primary objective is to deliver high current income and total return by investing across a broad range of credit and equity markets. BCAT seeks to achieve this objective through a portfolio of corporate debt securities, floating-rate loans, convertible securities, common and preferred equity, and asset-backed securities.
BCAT employs an actively managed, multi-sector credit approach that spans investment-grade and below-investment-grade bonds, senior secured loans and structured credit.
See Also
- Five stocks we like better than BlackRock Capital Allocation Term Trust
- YETI Rallies After Earnings Beat and Raised Outlook
- How the 3 Leading Quantum Firms Stack Up After Q1 Earnings
- Cisco’s Vertical Rally May Still Be in the Early Innings
- Amazon vs. Alibaba: One Is Clearly The Better Value Play right Now
Want to see what other hedge funds are holding BCAT? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for BlackRock Capital Allocation Term Trust (NYSE:BCAT – Free Report).
Receive News & Ratings for BlackRock Capital Allocation Term Trust Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for BlackRock Capital Allocation Term Trust and related companies with MarketBeat.com's FREE daily email newsletter.
